A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for Major Depressive Disorder
26 locations incl. Little Rock
Sponsor: Definium Therapeutics US, Inc.
Sex: All·Age: 18 - 74
Code: NCT07592689·Phase 3·Recruiting·Listed May 2026
Cleveland clinic
Clinical research site in Cleveland, Ohio · 9500 EUCLID AVE # C21, CLEVELAND, OH 44195-0001 · (216) 444-0522 · Website
Part of Cleveland Clinic
As of July 2026, 320 paid clinical trials are recruiting at Cleveland clinic in Cleveland, Ohio. Active studies at this site cover conditions such as Heart Failure, Cardiovascular Diseases and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Cleveland clinic (320)
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
for Diabetic Macular Edema
29 locations incl. Phoenix
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07553429·Phase 1, Phase 2·Recruiting·Listed Apr 2026
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for Chronic Idiopathic Constipation (CIC)
109 locations incl. Foley
Sponsor: Ardelyx
Sex: All·Age: 18 - 80
Code: NCT07382167·Phase 3·Recruiting·Listed Feb 2026
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
for Proteinuric Kidney Diseases
25 locations incl. Huntsville
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT07355296·Phase 2·Recruiting·Listed Jan 2026
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for Parkinson Disease
25 locations incl. Little Rock
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All·Age: 30 - 80
Code: NCT07432958·Phase 2·Recruiting·Listed Feb 2026
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
for Parkinson's Disease
26 locations incl. Phoenix
Sponsor: Bayer
Sex: All·Age: 45 - 75
Code: NCT07330258·Recruiting·Listed Jan 2026
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
for Breast Neoplasms
28 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: Female·Age: 18+
Code: NCT07287098·Phase 2·Recruiting·Listed Dec 2025
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for Ovarian Neoplasms
88 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
38 locations incl. Anchorage
Sponsor: Incyte Corporation
Sex: Female·Age: 18+
Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for Parkinson's Disease
46 locations incl. Birmingham
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 85
Code: NCT07174310·Phase 3·Recruiting·Listed Sep 2025
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
169 locations incl. Daphne
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
for Chronic Kidney Disease
30 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 2 - 17
Code: NCT07107945·Phase 3·Recruiting·Listed Aug 2025
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
86 locations incl. Huntsville
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for Multiple Myeloma
95 locations incl. Mobile
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06152575·Phase 3·Recruiting·Listed Nov 2023
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for Urothelial Cancer
33 locations incl. Gilbert
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07106762·Phase 2, Phase 3·Recruiting·Listed Aug 2025
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for Moderate Aortic Valve Stenosis
69 locations incl. Birmingham
Sponsor: Kardigan, Inc.
Sex: All·Age: 50+
Code: NCT07001800·Phase 2, Phase 3·Recruiting·Listed Jun 2025
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for Large B-cell Lymphoma
60 locations incl. Gilbert
Sponsor: Allogene Therapeutics
Sex: All·Age: 18+
Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
for Neovascular Age-related Macular Degeneration
33 locations incl. Mesa
Sponsor: Genentech, Inc.
Sex: All·Age: 50+
Code: NCT04853251·Phase 4·Recruiting·Listed Apr 2021
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for Leukemia, Myeloid, Acute
51 locations incl. Birmingham
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06852222·Phase 3·Recruiting·Listed Feb 2025
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for Small Cell Lung Cancer
27 locations incl. Daphne
Sponsor: Puma Biotechnology, Inc.
Sex: All·Age: 18+
Code: NCT06095505·Phase 2·Recruiting·Listed Oct 2023
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for Macular Edema Secondary to Inflammation
53 locations incl. Phoenix
Sponsor: Kodiak Sciences Inc
Sex: All·Age: 18+
Code: NCT06996080·Phase 3·Recruiting·Listed May 2025
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for Macular Edema Secondary to Inflammation
53 locations incl. Phoenix
Sponsor: Kodiak Sciences Inc
Sex: All·Age: 18+
Code: NCT06990399·Phase 3·Recruiting·Listed May 2025
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for Obstructive Hypertrophic Cardiomyopathy
62 locations incl. Anchorage
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05489705·Recruiting·Listed Aug 2022
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for Interstitial Lung Diseases
33 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06806592·Phase 3·Recruiting·Listed Feb 2025
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for Agitation
43 locations incl. Homewood
Sponsor: Celgene
Sex: All·Age: 55 - 90
Code: NCT06808984·Phase 2·Recruiting·Listed Feb 2025
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for Glioma
42 locations incl. Birmingham
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
for Migraine
26 locations incl. Phoenix
Sponsor: Pfizer
Sex: All·Age: 12 - 17
Code: NCT06616194·Phase 3·Recruiting·Listed Sep 2024
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
for Pancreatic Ductal Adenocarcinoma
25 locations incl. Duarte
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06586515·Phase 1·Recruiting·Listed Sep 2024
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
for Melanoma
31 locations incl. Fayetteville
Sponsor: Pfizer
Sex: All·Age: 16+
Code: NCT05355701·Phase 1·Recruiting·Listed May 2022
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
for Non-small Cell Lung Cancer
39 locations incl. Birmingham
Sponsor: BioNTech SE
Sex: All·Age: 18+
Code: NCT06712316·Phase 2, Phase 3·Recruiting·Listed Dec 2024
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
for Amyloidosis
39 locations incl. La Jolla
Sponsor: Eidos Therapeutics, a BridgeBio company
Sex: All·Age: 18 - 75
Code: NCT06563895·Phase 3·Recruiting·Listed Aug 2024
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for Heart Failure
85 locations incl. Alexander City
Sponsor: Cytokinetics
Sex: All·Age: 18 - 85
Code: NCT06736574·Phase 3·Recruiting·Listed Dec 2024
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
for Lupus Erythematosus, Systemic
40 locations incl. Phoenix
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 16+
Code: NCT07015983·Phase 2·Recruiting·Listed Jun 2025
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
for Metastatic Breast Cancer
31 locations incl. Scottsdale
Sponsor: LeonaBio
Sex: All·Age: 18+
Code: NCT05696626·Phase 3·Recruiting·Listed Jan 2023
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for Cutaneous Squamous Cell Carcinoma (CSCC)
44 locations incl. Phoenix
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06585410·Phase 3·Recruiting·Listed Sep 2024
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
for Dravet Syndrome
19 locations incl. Orange
Sponsor: Epygenix
Sex: All·Age: 2+
Code: NCT04462770·Phase 3·Recruiting·Listed Jul 2020
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for Adjustment Disorder
30 locations incl. Birmingham
Sponsor: Reunion Neuroscience Inc
Sex: All·Age: 18 - 80
Code: NCT07002034·Phase 2·Recruiting·Listed Jun 2025
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
for Head and Neck Squamous Cell Carcinoma
29 locations incl. Duarte
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT06163534·Recruiting·Listed Dec 2023
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for HER2 Mutation-Related Tumors
29 locations incl. La Jolla
Sponsor: Iambic Therapeutics, Inc
Sex: All·Age: 18+
Code: NCT06253871·Phase 1·Recruiting·Listed Feb 2024
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for Cancer
30 locations incl. Phoenix
Sponsor: Parabilis Medicines, Inc.
Sex: All·Age: 18+
Code: NCT05919264·Phase 1, Phase 2·Recruiting·Listed Jun 2023
Showing the 40 most relevant of 320 recruiting trials at this site. Browse all with filters →
More research sites in Cleveland
- University Hospitals Cleveland Medical Center (148 trials)
- Cleveland Clinic Foundation (147 trials)
- Case Western Reserve University (79 trials)
- MetroHealth Medical Center (33 trials)
- Rainbow Babies and Childrens Hospital (26 trials)
- The Cleveland Clinic Foundation (25 trials)
- Louis Stokes VA Medical Center, Cleveland, OH (24 trials)
- Cleveland Clinic Main Campus (21 trials)
- The Cleveland Clinic (17 trials)
- Cleveland Clinic Cancer Center/Fairview Hospital (14 trials)
Explore more
Paid clinical trials in Cleveland, OH · Ohio clinical trials